9068 Results

Congress Abstract

Radiomics for prediction of metastatic melanoma patient survival after immunotherapy

Authors: Gabrys|, Hubert(1)*[hubert.gabrys@gmail.com];Basler|, Lucas(1);Hogan|, Sabrina(2);Pavic|, Matea(1);Bogowicz|, Marta(1);Vuong|, Diem(1);Tanadini-Lang|, Stephanie(1);Förster|, Robert(1);Huellner|, Martin(3);Dummer|, Reinhard(2);Guckenberger|, Matthias(1);Levesque|, Mitchell P.(2);
(1)University Hospital Zurich, Department of Radiation Oncology, Zurich, Switzerland;(2)University Hospital Zurich, Department of Dermatology, Zurich, Switzerland;(3)University Hospital Zurich, Department of Nuclear Medicine, Zurich, Switzerland;
Show Affiliations

Journal Article

Machine learning for normal tissue complication probability prediction: Predictive power with versatility and easy implementation

Authors: Pratik Samant, Dirk de Ruysscher, Frank Hoebers, Richard Canters, Emma Hall, Chris Nutting, Tim Maughan, Frank Van den Heuvel

Congress Abstract

For the motion rebuttal

Authors:

Alfonso Gomez Iturriaga1

1Cruces University Hospital, Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, Spain

Show Affiliations

Congress Abstract

Alexithymia, empathy and burn-out amongst RTTs: results from the PRO BONO survey

Authors: Franco|, Pierfrancesco(1)*[pierfrancesco.franco@unito.it];Tesio|, Valentina(2);Bertholet|, Jenny(3);Gasnier|, Anne(4);Gonzalez del Portillo|, Elisabet(5);Spalek|, Mateusz(6);Bibault|, Jean-Emmanuel(7);Borst|, Gerben(8);van Elmpt|, Wouter(9);Thorwarth|, Daniela(10);Mullaney|, Laura(11);Roe Redalen|, Kathrine(12);Dubois|, Ludwig(13);Bittner|, Martin-Immanuel(14);Chargari|, Cyrus(15);Perryck|, Sophie(16);Heukelom|, Jolien(8);Petit|, Steven(17);Lybeer|, Myriam(18);Castelli|, Lorys(2);
(1)University of Turin, Department of Oncology- Radiation Oncology, Turin, Italy;(2)University of Turin, Department of Psychology, Turin, Italy;(3)The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Joint Department of Physics, London, United Kingdom;(4)Gustave Roussy Cancer Campus, Department of Medical Physics, Villejiuif, France;(5)University Hospital of Salamanca, Department of Radiation Oncology, Salamanca, Spain;(6)Maria Sklodowska-Curie Institute - Oncology Center, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland;(7)Hopital Europeen Georges Pompidou- Universite Paris Descartes, Department of Radiation Oncology, Paris, France;(8)The Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital, Department of Radiation Oncology, Amsterdam, The Netherlands;(9)GROW – School for Oncology and Developmental Biology- Maastricht University Medical Center, Department of Radiation Oncology, Maastricht, The Netherlands;(10)University Hospital for Radiation Oncology Tubingen, Section for Biomedical Physic, Tubingen, Germany;(11)Trinity College Dublin, Applied Radiation Therapy Trinity Research Group- Discipline of Radiation Therapy- School of Medicine, Dublin, Ireland;(12)Norwegian University of Science and Technology, Department of Physic, Trondheim, Norway;(13)GROW – School for Oncology and Developmental Biology- Maastricht University Medical Center, Department of Radiation Oncology, , The Netherlands;(14)Arctoris, Arctoris, Oxford, United Kingdom;(15)Gustave Roussy Cancer Campus, Department of Radiation Oncology, Villejiuf, France;(16)University Hospital Zurich and University of Zurich, Department of Radiation Oncology, Zurich, Switzerland;(17)Erasmus Medical Center, Department of Medical Physics, Rotterdam, The Netherlands;(18)ESTRO, ESTRO Office, Brussels, Belgium;
Show Affiliations

Congress Abstract

Outcomes and prognostic factors in neoadjuvant chemoradiotherapy for resectable esophageal cancer

Authors:

Raquel Benlloch Rodríguez1, Alfonso Valcárcel Díaz2, Marta López Valcárcel1, Jesús Romero Fernández1, Sofía Córdoba Largo1, Jose Luis Lucena de la Poza3, María Dolores Chaparro Cabezas3, María Hernández Miguel1, Beatriz Gil Haro1, Sofía Santana Jiménez1, Olga Engel1, Jorge Fernando Obeso Herrera1, Cristina De La Fuente1

1Puerta de Hierro University Hospital, Radiation Oncology, Madrid, Spain; 2Puerta de Hierro University Hospital, Radiation Oncology, Radiation Oncology, Madrid, Spain; 3Puerta de Hierro University Hospital, Surgery, Madrid, Spain

Show Affiliations

Webcast

Determinants of toxicity in pelvic radiotherapy

Authors: Renaud De Crevoisier

Journal Article

NHL-ChirEx: An interprofessional cross-border education initiative in the Greater Region with a focus on radiation morbidity and patient safety

Authors: Guillaume Vogin, Jochen Fleckenstein, Jean-Christophe Servotte, Philippe Nickers, Anne Ebersberger, Farid Mohammad, Isabelle Bragard, Philippe Coucke, Michel Untereiner, Didier Peiffert, Marc Braun

Journal Article

Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis

Authors: Sofia Spampinato, Lars U. Fokdal, Richard Pötter, Christine Haie-Meder, Jacob C. Lindegaard, Maximilian P. Schmid, Alina Sturdza, Ina M. Jürgenliemk-Schulz, Umesh Mahantshetty, Barbara Segedin, Kjersti Bruheim, Peter Hoskin, Bhavana Rai, Fleur Huang, Rachel Cooper, Elzbieta van der Steen-Banasik, Erik Van Limbergen, Marit Sundset, Henrike Westerveld, Remi A. Nout, Nina B.K. Jensen, Christian Kirisits, Kathrin Kirchheiner, Kari Tanderup

Congress Abstract

Automated multi-criteria treatment planning for adaptive HDR-BT for locally advanced cervical cancer

Authors:

Michelle Oud1, Inger-Karine Kolkman-Deurloo1, Jan-Willem Mens1, Danny Lathouwers2, Zoltán Perkó2, Ben Heijmen1, Sebastiaan Breedveld1

1Erasmus MC Cancer Institute, Radiation Oncology, Rotterdam, The Netherlands; 2Delft University of Technology, Radiation Science & Technology, Delft, The Netherlands

Show Affiliations
*:*